A

Amylyx Pharmaceuticals
D

AMLX

14.660
USD
1.12
(8.27%)
مغلق
حجم التداول
35,005
الربح لكل سهم
-2
العائد الربحي
-
P/E
-6
حجم السوق
1,609,954,882
الأفكار والتحليلات
هشام منسي
هشام منسي
منذ 6 أشهر
buy
2025-05-19 06:35
AMLX Chart
المزيد
الأخبار المقالات

العنوان: Amylyx Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.